SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $84,000 | +33.3% | 6,435 | +11.9% | 0.00% | – |
| Q1 2016 | $63,000 | +53.7% | 5,751 | +28.9% | 0.00% | – |
| Q4 2015 | $41,000 | +2.5% | 4,461 | -23.0% | 0.00% | – |
| Q3 2015 | $40,000 | +135.3% | 5,792 | +225.6% | 0.00% | – |
| Q2 2015 | $17,000 | +41.7% | 1,779 | +28.4% | 0.00% | – |
| Q1 2015 | $12,000 | 0.0% | 1,385 | -0.4% | 0.00% | – |
| Q4 2014 | $12,000 | 0.0% | 1,390 | -16.9% | 0.00% | – |
| Q3 2014 | $12,000 | +33.3% | 1,672 | -2.8% | 0.00% | – |
| Q2 2014 | $9,000 | +12.5% | 1,720 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | -11.1% | 1,720 | -0.2% | 0.00% | – |
| Q4 2013 | $9,000 | -70.0% | 1,723 | -70.6% | 0.00% | – |
| Q3 2013 | $30,000 | +87.5% | 5,859 | +83.2% | 0.00% | – |
| Q2 2013 | $16,000 | – | 3,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
| Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
| Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
| GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
| MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
| Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
| Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
| TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
| BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |